Search

WILKES E.A., SELBY A.L., COLE A.T., FREEMAN J.G., RENNIE M.J. & KHAN Z.H. (2011) European Journal of Cancer Care 20, 593-600 Poor tolerability of thalidomide in end-stage oesophageal cancer Oesophageal cancer cachexia is a significant clinical problem, resulting in excessive morbidity and mortality. In a pilot study, 10 patients with cachexia due to advanced cancer of the oesophagus gained weight, including lean tissue, after 14-day treatment with thalidomide. Here, we present randomised placebo controlled trial data over a 6-week period to test the hypothesis that thalidomide is superior to placebo in terms of weight gain in patients with cachexia caused by oesophageal cancer. Thalidomide, 200 mg daily, or an identical placebo was given to patients with advanced oesophageal cancer. Total body weight and lean body mass were assessed in addition to drug tolerability and performance indices. Thirty-four patients were recruited. Of these, six given thalidomide and 16 given placebo completed the protocol; all withdrawals were due to adverse drug reactions or complications of disease. Thalidomide showed no benefit over placebo in participants who completed the protocol. These data suggest that thalidomide is poorly tolerated in patients with advanced cancer of the oesophagus and may not ameliorate the progression of cachexia. In the absence of hard supportive evidence, off-licence treatment with thalidomide should be used with great caution as an adjunct to nutritional support in patients with advanced cancer. [ABSTRACT FROM AUTHOR]

Nanocrystalline powder of LiF: Mg,Cu,P phosphor has been synthesized by the chemical coprecipitation technique. Shape and size of these nanomaterials were observed by transmission electron microscope and atomic force microscope. The particles are of rod shapes having diameters from 50 to 80 nm and lengths varying within the range 0.4-0.7 mum. Pellets of these nanorods were irradiated by 48 MeV7Li3+ ions at different fluences in the range 1times1011-1times1014 ions/cm2 (with corresponding doses in the range 0.679-679 kGy) and their thermoluminescence (TL) properties have been studied. The TL glow curves are observed to have prominent peaks at around 588 K along with smaller one at around 410 K. The TL intensity of the former is found to increase with increasing the fluence, while that of the latter decreases. These behaviors are in contrast with those of the peaks induced by 137Cs gamma-rays. This modification in case of irradiation by ion beam has been attributed to the change in population of the luminescent/trapping centers due to the use of highly energetic ions. From these results, it is suggested that the nanorods of LiF:Mg,Cu,P might be used as detectors for mixed fields radiations such as space radiations. [ABSTRACT FROM PUBLISHER]